FATE - Fate Therapeutics Inc. (FATE) CEO Scott Wolchko on Q2 2020 Results - Earnings Call Transcript
Fate Therapeutics, Inc. (FATE)
Q2 2020 Earnings Conference Call
August 05, 2020 5:30 PM ET
Company Participants
Scott Wolchko - President & Chief Executive Officer
Dan Shoemaker - Chief Scientific Officer
Bob Valamehr - Chief Development Officer
Wayne Chu - Senior Vice President, Clinical Development
Conference Call Participants
Robyn Karnauskas - Truist Securities
Kelsey Goodwin - Guggenheim Securities
Daina Graybosch - SVB Leerink
Mara Goldstein - Mizuho
Peter Lawson - Barclays
Matt Biegler - Oppenheimer
Aaron Welch - H.C. Wainwright
Yigal Nochomovitz - Citigroup
Biren Amin - Jefferies
Jim Birchenough - Wells Fargo
Alethia Young